State of the science on controversial topics: orthodontic therapy and gingival recession (a report of the Angle Society of Europe 2013 meeting)
Options
BORIS DOI
Date of Publication
2013
Publication Type
Article
Division/Institute
Contributor
Johal, Ama | |
Kiliaridis, Stavros | |
Leitao, Pedro | |
Rosa, Marco | |
Weiland, Frank | |
Zachrisson, Björn |
Subject(s)
Series
Progress in orthodontics
ISSN or ISBN (if monograph)
2196-1042
Publisher
Springer
Language
English
Publisher DOI
PubMed ID
24325787
Description
BACKGROUND
Controversy exists in the literature between the role of orthodontic treatment and gingival recession. Whilst movement of teeth outside the alveolar bone has been reported as a risk factor for gingival recession, others have found no such association.
FINDINGS
The Angle Society of Europe devoted a study day to explore the evidence surrounding these controversies. The aim of the day was for a panel of experts to evaluate the current evidence base in relation to either the beneficial or detrimental effects of orthodontic treatment on the gingival tissue.
CONCLUSIONS
There remains a relatively weak evidence base for the role of orthodontic treatment and gingival recession and thus a need to undertake a risk assessment and appropriate consent prior to the commencement of treatment. In further prospective, well designed trials are needed.
Controversy exists in the literature between the role of orthodontic treatment and gingival recession. Whilst movement of teeth outside the alveolar bone has been reported as a risk factor for gingival recession, others have found no such association.
FINDINGS
The Angle Society of Europe devoted a study day to explore the evidence surrounding these controversies. The aim of the day was for a panel of experts to evaluate the current evidence base in relation to either the beneficial or detrimental effects of orthodontic treatment on the gingival tissue.
CONCLUSIONS
There remains a relatively weak evidence base for the role of orthodontic treatment and gingival recession and thus a need to undertake a risk assessment and appropriate consent prior to the commencement of treatment. In further prospective, well designed trials are needed.
File(s)
| File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
|---|---|---|---|---|---|---|---|
| 2196-1042-14-16.pdf | text | Adobe PDF | 194.22 KB | Attribution (CC BY 4.0) | published |